Skip to main content

Upcoming Roundup Trial Postponed: Bayer

Upcoming Roundup Trial Postponed: Bayer

Upcoming Roundup Trial Postponed: Bayer

Introduction

On Sunday, Bayer said in a statement, the upcoming trial date October 15, 2019, for Winston v. Monsanto in St. Louis City has been postponed with a court status conference in February 2020.

The Winston lawsuit, involving 14 plaintiffs, was filed in March 2018. The lawsuit is among the pending cases against Bayer claiming that exposure to the company’s glyphosate-based herbicide Roundup, caused them to develop Non-Hodgkin lymphoma, and the manufacturers deceived about the risks associated with it. 

The lawsuit was the latest that had been set for trial in the St. Louis area, involving mediator Ken Feinberg, who is trying to negotiate a settlement between the company and U.S. plaintiffs. Judge Michael Mullen had scheduled the trial date for the lawsuit. According to a court document from the Circuit Court of the City of St. Louis, dated October 4, a status conference to reevaluate the case had been set for February 10.

Currently, Bayer is facing more than 18,400 claims, each involving similar allegations that Roundup causes Non-Hodgkin's lymphoma and other cancers. Roundup lawsuits are consolidated under federal multidistrict litigation (MDL No. 2741; In Re: Roundup Products Liability Litigation) in the Northern District of California, presided by U.S. District Judge Vince Chhabria.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!